UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II Journal article
Takayanagi T., Forrester S.J., Kawai T., Obama T., Tsuji T., Elliott K.J., Nuti E., Rossello A., Kwok H.F., Scalia R., Rizzo V., Eguchi S.. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II[J]. Hypertension, 2016, 68(4), 949-955.
Authors:  Takayanagi T.;  Forrester S.J.;  Kawai T.;  Obama T.;  Tsuji T.; et al.
Favorite | TC[WOS]:69 TC[Scopus]:71 | Submit date:2018/12/19
End-organ Damage  Fibrosis  Hypertension  Renin Angiotensin System  Signal Transduction  
Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro Conference paper
Kawai, T., Forrester, S. J., Eguchi, K., Rizzo, V., Eguchi, S., Kwok, H. F., Murphy, G., Rossello, A.. Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro[C], Dallas, TX:American Heart Association, 2016, Suppl 1 ---.
Authors:  Kawai, T.;   Forrester, S. J.;  Eguchi, K.;  Rizzo, V.;  Eguchi, S.; et al.
Favorite |  | Submit date:2022/06/02
Angiotensin II  Signal Transduction  EGFR  
Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro Conference paper
Kawai, T., Forrester, S. J., Eguchi, K., Rizzo, V., Eguchi, S., Kwok, H. F., Murphy, G., Rossello, A.. Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro[C], Dallas, TX:American Heart Association, 2016, Suppl 1 ---.
Authors:  Kawai, T.;   Forrester, S. J.;  Eguchi, K.;  Rizzo, V.;  Eguchi, S.; et al.
Favorite |  | Submit date:2022/06/02
Angiotensin II  Signal Transduction  EGFR